Impedance Measurements in Heart Failure Patients

Medtronic BRC3 sites in 3 countries20 target enrollmentDecember 2011

Overview

Phase: Phase 1
Intervention: Not specified
Conditions: Heart Failure
Sponsor: Medtronic BRC
Enrollment: 20
Locations: 3
Primary Endpoint: Impedance Measurement of Patients in Heart Failure, impedance change first to last measurement
Status: Terminated
Last Updated: 11 years ago

The purpose of this study is to measure impedance during inpatient treatment.

Registry

clinicaltrials.gov

Start Date

December 2011

End Date

May 2014

Last Updated

11 years ago

Study Type

Interventional

Study Design

Single Group

Sex

All

Sponsor

Medtronic BRC

Responsible Party

Sponsor

•patients who will require adrenergic or positive inotropic medications
•patients enrolled in a concurrent study that may confound the results of this study
•patients unable or unwilling to participate in study procedures
•patients who are pregnant
•patients who are mentally handicapped or legal incompetent
•patients who are dependent on investigator or sponsor

Impedance Measurement of Patients in Heart Failure, impedance change first to last measurement

Time Frame: every 4 hours up to 48 hours

Correlation between hemodynamic (central venous or arterial pressure) and impedance measurements (optional)(every 4 hours up to 48 hours)
Accuracy of Respiratory rate determined by impedance measurements(every 4 hours up to 48 hours)